Concepedia

Gregory D. Espenan

GD

12

Publications

720

Citations

10

H-Index

1998

Active since

Affiliations

University Medical Center New Orleans(Current)

Louisiana State University Health Sciences Center New Orleans

Louisiana State University

Excel Diagnostics Imaging

The Ohio State University

Gregory D. Espenan is an author at University Medical Center New Orleans specializing in medicine, radiation oncology, and oncology.

Top concepts

Publications per year

1998–2014

12

Publications

12

Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies

Lowell Anthony, Eugene A. Woltering, Gregory D. Espenan et al. · Seminars in Nuclear Medicine · 2002 · 277 citations

, , +4

Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Patients With Somatostatin Receptor–Expressing Neuroendocrine Tumors

Ebrahim S. Delpassand, Amin Samarghandi, Sara Zamanian et al. · Pancreas · 2014 · 132 citations

Growing vascular endothelial cells express somatostatin subtype 2 receptors

James C. Watson, Douglas A. Balster, B Gebhardt et al. · British Journal of Cancer · 2001 · 90 citations · Full text

Safety and Efficacy of Radionuclide Therapy with High-Activity In-111 Pentetreotide in Patients with Progressive Neuroendocrine Tumors

Ebrahim S. Delpassand, Jennifer Sims‐Mourtada, Hitomi Saso et al. · Cancer Biotherapy and Radiopharmaceuticals · 2008 · 52 citations

Progressive nuclear translocation of somatostatin analogs.

Conrad A. Hornick, Catherine T. Anthony, Susan Hughey et al. · PubMed · 2000 · 51 citations

, , +19

Rows per page

1–5 of 12